Anaplasmosis

Forbisen, 2,2, 3,3 -tetramethyl-l,l -diphenyl-4,4 -bi-3,3 -pyrazoline-5,5 -dione (706) (B-76MI40404), a by-product obtained in the manufacture of antipyrine, has been used in bovine anaplasmosis. 

Imidocarb is a carbanilide used for treatment and prophylaxis of piroplas-mosis and anaplasmosis. It can be administered by subcutaneous or intramuscular injection to cattle, sheep, and horse at dosages of 1.2-3.4 mg/kg bw. 

This is a disease of sheep and cattle prevalent in many parts of Asia, Africa and Southern U.S.A. The disease is caused by Anaplasma ovis (sheep) and A. tnargi-nale (cattle) and is responsible for heavy mortality in ruminants. Since anaplasmosis is a tick-borne disease, it is usually grouped with babesiasis and theileriasis. However, some workers consider Anaplasma to belong to order Rickettsiales and, therefore, should not be treated as protozoa at all [61]. 

Anaplasmosis Anaplasma spp. Tetracycline, oxytetracycline, chlortetracycline, imidocarb dipropionate, gloxazone. 

Gloxazone (8a), a bishydrazinocarbothioamide, which may be regarded to have been derived from thiourea, has been used to treat acute anaplasmosis in domestic animals [7],... 

Chapman AS, Bakken JS, Folk SM, et al. Diagnosis and management of tickborne rickettsial diseases Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis—United States A practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep. 2006 55 1-27. 

Key Words Anaplasma phagocytophilum, granulocytic anaplasmosis cell culture fluorescent labeling neutrophils. 

Infectious diseases (e.g., leptospirosis, bacillary hemoglobinuria, babesiosis, anaplasmosis)... 

Alhumaidan H, Westley B, Esteva C, Berardi V, Young C, Sweeney J. Transfusion-transmitted anaplasmosis from leukoreduced red blood cells. Transfusion 2013 53(l) 181-6. 

Jereb M, Pecaver B, Tomazic J, Muzlovic 1, Avsic-Zupanc T, Premru-Srsen T, et al. Severe human granulocytic anaplasmosis transmitted by blood transfusion. Emerg Infect Dis 2012 18(8) 1354-7. 

---